Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Report

Global and Region Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：155
  • REPORT CODE：GMM983819
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drugmarket, defines the market attractiveness level of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug industry, describes the types of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug market and the development prospects and opportunities of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug market in Chapter 13.

    By Player:

    • Porton

    • Grifols International, SA

    • Nectar Lifesciences

    • Boehringer Ingelheim

    • Vetter

    • Asymchem

    • Lonza AG

    • Almac Group

    • CMIC Group

    • Catalent

    • WuXi AppTec

    • AbbVie Inc

    • Aenova Group

    • Recipharm

    • PCI

    • Patheon

    By Type:

    • Blood Factors

    • Cytokines

    • Peptide Hormone

    • Immunoglobulin

    • Insulin

    • Other Drug Classes

    By End-User:

    • Pharma Company

    • Biotech Company

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis and Outlook to 2022

    • 7.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)

    • 7.2 United States Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)

    • 7.3 Europe Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)

    • 7.4 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)

    • 7.5 Japan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)

    • 7.6 India Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)

    • 7.7 South Korea Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption (2017-2022)

    8 Region and Country-wise Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis and Outlook to 2028

    • 8.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)

    • 8.2 United States Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)

    • 8.4 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)

    • 8.6 India Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast (2022-2028)

    9 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Factors Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cytokines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Peptide Hormone Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Immunoglobulin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Other Drug Classes Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharma Company Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Biotech Company Consumption and Growth Rate (2017-2022)

    10 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Blood Factors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Cytokines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Peptide Hormone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Pharma Company Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Biotech Company Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Competitive Analysis

    • 14.1 Porton

      • 14.1.1 Porton Company Details

      • 14.1.2 Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.2 Grifols International, SA

      • 14.2.1 Grifols International, SA Company Details

      • 14.2.2 Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.3 Nectar Lifesciences

      • 14.3.1 Nectar Lifesciences Company Details

      • 14.3.2 Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.4 Boehringer Ingelheim

      • 14.4.1 Boehringer Ingelheim Company Details

      • 14.4.2 Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.5 Vetter

      • 14.5.1 Vetter Company Details

      • 14.5.2 Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.6 Asymchem

      • 14.6.1 Asymchem Company Details

      • 14.6.2 Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.7 Lonza AG

      • 14.7.1 Lonza AG Company Details

      • 14.7.2 Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.8 Almac Group

      • 14.8.1 Almac Group Company Details

      • 14.8.2 Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.9 CMIC Group

      • 14.9.1 CMIC Group Company Details

      • 14.9.2 CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.10 Catalent

      • 14.10.1 Catalent Company Details

      • 14.10.2 Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.11 WuXi AppTec

      • 14.11.1 WuXi AppTec Company Details

      • 14.11.2 WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.12 AbbVie Inc

      • 14.12.1 AbbVie Inc Company Details

      • 14.12.2 AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.13 Aenova Group

      • 14.13.1 Aenova Group Company Details

      • 14.13.2 Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.14 Recipharm

      • 14.14.1 Recipharm Company Details

      • 14.14.2 Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.15 PCI

      • 14.15.1 PCI Company Details

      • 14.15.2 PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • 14.16 Patheon

      • 14.16.1 Patheon Company Details

      • 14.16.2 Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug

    • Figure Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Picture

    • Table Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption by Country (2017-2022)

    • Figure United States Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)

    • Figure India Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Factors Consumption and Growth Rate (2017-2022)

    • Figure Global Cytokines Consumption and Growth Rate (2017-2022)

    • Figure Global Peptide Hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Immunoglobulin Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Other Drug Classes Consumption and Growth Rate (2017-2022)

    • Figure Global Pharma Company Consumption and Growth Rate (2017-2022)

    • Figure Global Biotech Company Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cytokines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Peptide Hormone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharma Company Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biotech Company Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Porton (Foundation Year, Company Profile and etc.)

    • Table Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Porton Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Grifols International, SA (Foundation Year, Company Profile and etc.)

    • Table Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Nectar Lifesciences (Foundation Year, Company Profile and etc.)

    • Table Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Vetter (Foundation Year, Company Profile and etc.)

    • Table Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Asymchem (Foundation Year, Company Profile and etc.)

    • Table Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Asymchem Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Lonza AG (Foundation Year, Company Profile and etc.)

    • Table Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Almac Group (Foundation Year, Company Profile and etc.)

    • Table Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table CMIC Group (Foundation Year, Company Profile and etc.)

    • Table CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Catalent (Foundation Year, Company Profile and etc.)

    • Table Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catalent Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table WuXi AppTec (Foundation Year, Company Profile and etc.)

    • Table WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Aenova Group (Foundation Year, Company Profile and etc.)

    • Table Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aenova Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Recipharm (Foundation Year, Company Profile and etc.)

    • Table Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Recipharm Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table PCI (Foundation Year, Company Profile and etc.)

    • Table PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table PCI Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service

    • Table Patheon (Foundation Year, Company Profile and etc.)

    • Table Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Patheon Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US